192 results on '"Villemagne, Victor L."'
Search Results
2. Longitudinal trajectories of basal forebrain volume in normal aging and Alzheimer’s disease
3. β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3
4. Insulin resistance, cognition and Alzheimer's disease biomarkers: Evidence that CSF Aβ42 moderates the association between insulin resistance and increased CSF tau levels
5. PET Imaging of brain muscarinic receptors with 18F-Fluorobenzyl-Dexetimide: A first in human study
6. Androgen receptor CAG repeat length as a moderator of the relationship between free testosterone levels and cognition
7. Advances in Brain Amyloid Imaging
8. Non-negative matrix factorisation improves Centiloid robustness in longitudinal studies
9. Mesial temporal tau is related to worse cognitive performance and greater neocortical tau load in amyloid-β–negative cognitively normal individuals
10. Impact of APOE-ε4 carriage on the onset and rates of neocortical Aβ-amyloid deposition
11. Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
12. Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study
13. Rates of age- and amyloid β-associated cortical atrophy in older adults with superior memory performance
14. A harmonized longitudinal biomarkers and cognition database for assessing the natural history of preclinical Alzheimer's disease from young adulthood and for designing prevention trials
15. Comparison of 18F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL® approaches: Validation against histopathology
16. Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology
17. Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD
18. Implementing the centiloid transformation for 11C-PiB and β-amyloid 18F-PET tracers using CapAIBL
19. Estimates of age-related memory decline are inflated by unrecognized Alzheimer's disease
20. The effect of preclinical Alzheimer's disease on age-related changes in intelligence in cognitively normal older adults
21. Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts
22. Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
23. Amyloid burden and incident depressive symptoms in preclinical Alzheimer’s disease
24. Cognitive gene risk profile for the prediction of cognitive decline in presymptomatic Alzheimer’s disease
25. Neuropsychology and neuroimaging profiles of amyloid-positive versus amyloid-negative amnestic mild cognitive impairment patients
26. Tau positron emission tomography using [18F]THK5351 and cerebral glucose hypometabolism in Alzheimer's disease
27. A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study
28. Plasma Cortisol, Brain Amyloid-β, and Cognitive Decline in Preclinical Alzheimer’s Disease: A 6-Year Prospective Cohort Study
29. Amyloid β–associated cognitive decline in the absence of clinical disease progression and systemic illness
30. Assessment of amyloid β in pathologically confirmed frontotemporal dementia syndromes
31. Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
32. Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort
33. Aβ-amyloid and Tau Imaging in Dementia
34. Divergent Network Patterns of Amyloid-β Deposition in Logopenic and Amnestic Alzheimer’s Disease Presentations
35. Untangling tau imaging
36. Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging
37. Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score
38. Computer-aided detection of cerebral microbleeds in susceptibility-weighted imaging
39. Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing
40. APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease
41. Comparison of MR-less PiB SUVR quantification methods
42. Aβ and cognitive change: Examining the preclinical and prodromal stages of Alzheimer's disease
43. An increased neutrophil–lymphocyte ratio in Alzheimer's disease is a function of age and is weakly correlated with neocortical amyloid accumulation
44. In vivo tau imaging: Obstacles and progress
45. Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease
46. BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease
47. Aβ amyloid, cognition, and APOE genotype in healthy older adults
48. Amyloid Imaging with PET in Early Alzheimer Disease Diagnosis
49. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
50. Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.